Publish Date: 
Thursday, September 16, 2021 - 09:00

$10 Million Investment for Melanoma Screening Program

Queenslanders could have skin cancer diagnosed earlier using world-first 3D scanning technology with the launch of the Australian Centre of Excellence in Melanoma Imaging and Diagnosis (ACEMID) initiative.

Launched at TRI on Monday 13 September, UQ Dermatologist Professor H. Peter Soyer said the technology enabled researchers to track moles and skin spots over time using full body mapping, making it a game-changer for melanoma detection.

"This technology is revolutionising early melanoma detection using 3D state-of-the-art body imaging systems that take an image in milliseconds,” Professor Soyer said.

The project brings together three leading Australian universities in skin research, The University of Queensland, The University of Sydney and Melbourne’s Monash University, to form the interconnected Centre of Excellence in Diagnostic Imaging of Early Melanoma.

The new Centre can access a national database of up to 100,000 patient images taken by 3D full body imaging systems located in Queensland, NSW and Victoria, as part of the world’s largest melanoma imaging trial, which aims to develop more efficient and effective screening for the early detection of skin cancer.

Queenslanders can sign up here to be part of the world’s largest melanoma imaging trial using the 3D full body imaging system located at Brisbane’s Princess Alexandra Hospital.

Pictured: Mr Tim Crommelin, ACRF Board member, The Hon Mrs Julieanne Gilbert, Assistant Minister for Health and Regional Health Infrastructure, Professor H. Peter Soyer, Director, Dermatology Research Centre, The University of Queensland and Professor Deborah Terry AO, Vice-Chancellor and President, The University of Queensland.  

This story was first published by The University of Queensland.